{"author": "Bhatia, D ", "adress": "Shenandoah Univ, Bernard J Dunn Sch Pharm, 3225 Gallows Rd, Fairfax, VA 22031 USA", "emails": ["dbhatia@su.edu"], "title": "GADD45 alpha-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status"}